Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00619Imatinib1Terminated1
DB06300Ponatinib1 / 2Active Not Recruiting1
DB06300PonatinibNot AvailableApproved for Marketing1
DB08901PonatinibNot AvailableApproved for Marketing1